News
Heart study shows lower cardiovascular risks than 1960s

People are living longer and with less risk of having a heart attack, stroke or dying from coronary heart disease than those in the 1960s and 1970s.
That’s according to new analysis of the historic Framingham Heart Study that underscores the power of prevention, screening and treatment efforts.
Scientists have known for decades about the risks posed by plaque buildup in the arteries. Coronary heart disease, for example, caused 360,900 deaths in the US in 2019, according to statistics from the American Heart Association.
But researchers wanted to learn more about how the risk has changed over the years. To do that, they focused on ‘remaining lifetime risk’ or the probability that a person, at any given age, will experience cardiovascular disease during their remaining years.
Researchers used data from the ongoing Framingham Heart Study that started in 1948 and now includes participants from multiple generations.
The investigators calculated participants’ remaining lifetime risk from age 45 for having a heart attack or stroke or dying from coronary heart disease during three epochs: 1960-1979, 1980-1999 and 2000-2018.
Life expectancy rose by 10.1 years for men and 11.9 years for women across the three time periods. The remaining lifetime risk of cardiovascular disease fell between 1960-1979 and 2000-2018 – from 36.3 per cent to 26.5 per cent in women, and from 52.5 per cent to 30.1 per cent in men.
Researchers also found men and women in the 21st century were having their first cardiovascular disease events later in life.
From 2000-2018, the average age of a first cardiovascular event was 8.1 years later for men and 10.3 years later for woman compared with 1960-1979.
“It’s a very strong message of prevention and hope,” said Dr Vasan Ramachandran, lead author of the study published Monday in the AHA journal Circulation.
“This tells us that better health care access, preventive measures, smoking cessation and better treatment of high blood pressure and cholesterol may be helpful in lowering the lifetime probability of developing a heart attack or a stroke.”
The other success story is “we are postponing the onset of heart attacks and strokes by as much as a decade. We’re increasing the period of living with good health,” said Ramachandran, chief of preventive medicine and epidemiology at Boston University’s School of Medicine and School of Public Health.
Stay healthy
With the pandemic easing up, people who haven’t seen a doctor in a while should schedule an exam and have their blood pressure, blood sugar and cholesterol checked, he said.
“The findings show us that the benefits of prevention, screening and proper treatment accrue. If you do these things in middle age, you’re rewarded with healthy life years later.”
He said the study was limited by its focus on a largely white population in the northeastern US, and future studies are needed in more diverse populations living in different areas.
Ramachandran also called for further research into gender differences because the findings for the most recent time period showed remaining lifetime risk of coronary heart disease was higher in men, but with stroke, it was higher in women.
“We need a deeper dive and a deeper understanding of why this might be the case,” he said.
Monica Serra, who was not involved in the study, said new research is needed to see if rising rates of obesity and diabetes “will counteract the gains observed from our current medical and technological advancements.”
Despite the progress shown in the study, the overall risk of cardiovascular disease remains high, “highlighting the need for continued screening and primary prevention efforts, as well as identification of more effective and widely accessible screening and treatment options,” said Serra, an associate professor and research health scientist at the University of Texas Health Science Center at San Antonio.
Even with medical advancements and better treatments, it’s important for people to take charge of their own heart health, Serra said.
They can do that by adopting a healthier lifestyle earlier in life and being aware of their heart disease and stroke risks, “particularly those that are modifiable – blood pressure, cholesterol and diabetes control, and smoking reduction.”
News
Gut-friendly foods may damage heart, charity warns
News
Diabetes patients face increased risk of undiagnosed heart failure

People with diabetes may have undiagnosed heart failure that could be detected by a simple screening blood test, research suggests.
The TARTAN-HF trial found that one in four patients with diabetes who had at least one other risk factor for heart failure had undiagnosed heart failure detected through screening with a blood test and ultrasound scanning of the heart.
Experts said the findings show the extent of unrecognised heart failure in people with diabetes, and how the condition can be detected using a widely available blood test called NT-proBNP, which measures how much strain the heart is under.
They suggest a heart failure screening programme for diabetics could improve diagnosis rates, lead to earlier treatment and potentially reduce the risk of hospitalisation and death.
The study, involving 700 patients, was led by the University of Glasgow in collaboration with AstraZeneca, Roche Diagnostics, Us2.ai, NHS Greater Glasgow and Clyde and NHS Lanarkshire.
Dr Kieran Docherty, clinical senior lecturer at the University of Glasgow’s School of Cardiovascular and Metabolic Health, said: “Our results from the landmark TARTAN-HF trial identified heart failure in a large proportion of people living with diabetes, emphasising the need for a heart failure screening strategy in this group of patients.
“We know that many of the symptoms and signs of heart failure are non-specific, and may go unrecognised as potentially being due to heart failure for a long time.
“The strategy used in our trial is simple and easy to implement in clinical practice, and will aid in the early identification of heart failure in people with diabetes, and facilitate the initiation of medications that we know improve outcomes in patients with heart failure.”
The study, which began more than three years ago, involved more than 700 people with diabetes from the two health board areas who had at least one other risk factor for heart failure.
They were randomly assigned either to receive heart failure screening or to continue with their usual care.
Researchers found screening uncovered a large number of previously unrecognised cases of heart failure. Around one in four, or 24.9 per cent, of those screened were found to have the condition within six months, compared with 1 per cent in the group continuing their usual care.
The study, involving patients with type 1 and type 2 diabetes, found almost all of the participants found to have heart failure had preserved ejection fraction, which can be difficult to detect without dedicated testing.
The findings of the TARTAN-HF trial were presented at the American College of Cardiology conference taking place from 28 to 30 March in New Orleans in the US.
Dr Edward Piper, medical director at AstraZeneca UK, said: “Delayed diagnosis and treatment of heart failure in people with type 2 diabetes contributes to poor long-term outcomes. TARTAN-HF demonstrates that targeted, risk-based screening can identify previously undiagnosed heart failure in approximately one in four high-risk patients with diabetes, enabling earlier intervention with guideline-directed therapy.”
Dr Christian Simon, head of global medical affairs at Roche Diagnostics, said: “We are proud to have supported the landmark TARTAN-HF trial. These findings demonstrate the transformative power of early, accessible diagnostics like the NT-proBNP blood test.
“By identifying unrecognised heart failure in people with diabetes, we enable clinicians to initiate appropriate treatments sooner, ultimately improving patient outcomes and lives.”
News
UK government announces £6.3m fund to boost men’s health

The UK has launched a £6.3m men’s health fund to back local projects aimed at helping men and boys live longer, healthier lives.
The Men’s Health Community Fund is a partnership between the Department of Health and Social Care, Movember and People’s Health Trust.
The government is contributing £3m, while the two charities are more than doubling that to take the total to £6.3m.
Grants will support community projects reaching underserved men and boys aged 16 and over, particularly in the most disadvantaged areas and at key points in their lives such as becoming a father, losing a job or retiring.
Projects could include support for new fathers, activities for men facing loneliness and social isolation, services to help young men engage with the health system, and support for men in work, out of work and moving into retirement.
The programme will bring together voluntary, community and social enterprise organisations to test new ways of reaching men who are least likely to use traditional health services.
An evaluation funded through the National Institute for Health and Care Research will assess what works and help inform future policy and delivery.
Health and social care secretary Wes Streeting said: “Too many men across the country are living shorter, less healthy lives, particularly those in our most disadvantaged communities.
“This new partnership will help men get the support they need in the places they feel most comfortable, their communities, among people they trust.
“By working with expert charities and local organisations, we can reach the men who are too often missed by traditional services and help them take better care of their mental and physical health.”
“It is a key step in delivering our first ever Men’s Health Strategy and driving forward our ambition to halve the gap in healthy life expectancy between the richest and poorest areas.”
The Men’s Health Strategy sets out plans to tackle the physical and mental health challenges men and boys face.
Men can be less likely to seek help and more likely to suffer in silence, while higher rates of smoking, drinking, gambling and drug use are damaging men’s health and affecting families, workplaces and communities.
The government is also investing £3.6m over the next three years in suicide prevention projects for middle-aged men in local communities across areas of England where men are most at risk, many of which are also among the most deprived. Suicide is one of the biggest killers of men under 50, and three-quarters of all suicides are men.
The projects will aim to break down barriers middle-aged men face in seeking support, including stigma around asking for help and a lack of awareness of what is available and how to access it.
They will be co-designed with experts and men with lived experience of mental health crises and suicidal thoughts.








